Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.
Patent On AIDS Medicine Denied In India; Seen Unlocking Market
India rejects US firms patent for anti-HIV drugs
Indian Patent Office Rejects Abbott’s Kaletra Patent
Patent Denied On AIDS Drug In India
Patent office rejects Abbott’s application on HIV drug
India rejects Abbott patent on Kaletra
India rejects HIV drug patent
For once no Patents please
India Allows Use of Generic Versions of Abbott AIDS Drug: Biotech’s Latest Tribulations
India rejects unmerited patent application by Abbott for HIV drug